Read our Feature in Fierce Pharma →
MLR isn’t linear, your platform shouldn’t be either. ERMA Evaluate™ uses AI to identify claims, assign references, streamline workflows and ensure FDA-compliant content.
ERMA Evaluate uses AI to identify claims, assign references, and streamline MLR workflows, ensuring every asset is review-ready with validated claims and compliance.
Ensure marketing materials align with current FDA guidelines using ERMA’s FDA Knowledge Base. The platform maintains a repository of FDA enforcement letters and regulatory updates, allowing teams to establish their own compliance rules and automatically evaluate promotional materials against evolving FDA standards.
ERMA Evaluate automatically detects scientific and promotional claims directly within marketing materials, eliminating the need to manually create and maintain claims databases. By identifying claims dynamically within the content, ERMA ensures reviewers can focus on evaluating messaging rather than managing claims infrastructure.
Every organization structures promotional review differently. ERMA Evaluate provides configurable workflows that adapt to your internal processes rather than forcing teams into rigid review structures.
ERMA is designed to work alongside the systems life sciences teams already rely on. Through flexible APIs and configurable connectors, ERMA integrates with legacy platforms. This allows organizations to enhance their MLR process with AI-driven claim identification, reference assignment, and compliance validation without replacing their current infrastructure.
Decrease in the number of review cycles
Faster reviews from submission to approval
AI claim detection accuracy across all assets
Accelerate promotional review for drug launches, indication expansions, and campaign updates — without sacrificing compliance.
Manage claims, references, and regulatory submissions for device marketing materials across every review cycle.
Streamline MLR workflows for veterinary and animal health promotional materials with the same rigor as human therapeutics.
Navigate the complex promotional review requirements of cutting-edge therapies with a platform built for regulatory precision.
As pharmaceutical companies face increasing pressure to produce more content across more channels, the Medical, Legal, and Regulatory review process is under strain.
Every promotional asset — from digital campaigns to congress materials and sales tools — must pass through Medical, Legal, and Regulatory review.
MIAMI–(BUSINESS WIRE)–ERMA Systems™, the AI-powered compliance platform redefining how life-sciences companies approach promotional review.
ERMA Evaluate™ identifies claims, assigns references, and flags FDA risk, reducing review cycles and accelerating approvals.